Hyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantation

Clinical Transplantation

Volumn 25, Issue 4, 2011, Pages 638-645

  Moini, Maryam ^a   Hoseini Asl, Mohammad Kazem ^a   Taghavi, Seyed Alireza ^a   Sagheb, Mohammad M ^a   Nikeghbalian, Saman ^a   Salahi, Heshmatalah ^a   Bahador, Ali ^a   Motazedian, Motahareh ^a   Jafari, Peyman ^a   Malek Hosseini, Sayed Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ascites; Hyponatremia; Liver transplant waiting list; Model for end stage liver disease; Mortality

Indexed keywords

SODIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HYPONATREMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORING; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SODIUM BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SODIUM; SURVIVAL RATE; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS; YOUNG ADULT;

EID: 80051704386     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01350.x     Document Type: Article

References (27)

1. Malinchoc M, Kamath PS, Gordon FD et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000: 31: 864.
2. Freeman RB Jr, Wiesner RH, Harper A et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002: 8: 851.
3. Asbert M, Gines A, Gines P et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993: 104: 1485.
4. Henriksen JH, Bendtsen F, Gerbes AL et al. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, betaadrenergic blockade and atrial natriuretic factor. Hepatology 1992: 16: 1163.
5. Arroyo V, Bosch J, Gaya-Beltran J et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med 1981: 94: 198.
6. Gines A, Escorsell A, Gines P et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993: 105: 229.
7. Heuman DM, Abou-Assi SG, Habib A et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004: 40: 802.
8. Ruf AE, Kremers WK, Chavez LL et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005: 11: 336.
9. Biggins SW, Rodriguez HJ, Bacchetti P et al. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology 2005: 41: 32.
10. Biggins SW, Kim WR, Terrault NA et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006: 130: 1652.
11. Kim WR, Biggins SW, Kremers WK et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008: 359: 1018.
12. Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001: 33: 464.
13. Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996: 23: 164.
14. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 1953: 32: 1025.
15. Abelmann WH. Hyperdynamic circulation in cirrhosis: a historical perspective. Hepatology 1994: 20: 1356.
16. Groszmann RJ. Hyperdynamic circulation of liver disease 40years later: pathophysiology and clinical consequences. Hepatology 1994: 20: 1359.
17. Bosch J, Arroyo V, Betriu A et al. Hepatic hemodynamics and the rennin angiotensin aldosterone system in cirrhosis. Gastroenterology 1980: 78: 92.
18. Albillos A, Colombato LA, Groszmann RJ. Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 1992: 102: 931.
19. La VillaG, Salmeron JM, Arroyo V et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology 1992: 102: 2114.
20. Wong F, Sniderman K, Liu P et al. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 1995: 122: 816.
21. Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology 2002: 122: 1658.
22. Bataller R, Gines P, Arroyo V, Rodes J. Hepatorenal syndrome. Clin Liver Dis 2000: 4: 487.
23. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003;362:1819.
24. Borroni G, Maggi A, Sangiovanni A et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 2000: 32: 605.
25. Vila MC, Coll S, Sola R, Andreu M, Gana J, Marquez J. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia. Am J Gastroenterol 1999: 94: 2219.
26. Porcel A, Diaz F, Rendon P et al. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002: 162: 323.
27. Schepke M, Roth F, Koch L et al. Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding. Digestion 2003: 67: 146.